Search Results - "LORBER, Marc I"

Refine Results
  1. 1
  2. 2
  3. 3

    Engraftment of a vascularized human skin equivalent by Schechner, Jeffrey S., Crane, Saara K., Wang, Feiya, Szeglin, Anya M., Tellides, George, Lorber, Marc I., Bothwell, Alfred L. M., Pober, Jordan S.

    Published in The FASEB journal (01-12-2003)
    “…ABSTRACT Clinical performance of currently avail able human skin equivalents is limited by failure to develop perfusion. To address this problem we have…”
    Get full text
    Journal Article
  4. 4

    Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data by Lorber, Marc I, Ponticelli, Claudio, Whelchel, John, Mayer, Hartmut W, Kovarik, John, Li, Yulan, Schmidli, Heinz

    Published in Clinical transplantation (01-04-2005)
    “…:  The aims of the current study were to determine whether therapeutic drug monitoring (TDM) might benefit kidney transplant recipients receiving everolimus,…”
    Get full text
    Journal Article
  5. 5

    The role of industry in advancing xenotransplantation by Shin, Jordan T., Rothblatt, Martine A., Lorber, Marc I.

    Published in Current opinion in organ transplantation (01-10-2019)
    “…Xenotransplantation offers the opportunity to alleviate the imbalance between the demand of patients with end stage organ failure and the supply of organs…”
    Get full text
    Journal Article
  6. 6
  7. 7

    T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase by Koh, Kian Peng, Wang, Yinong, Yi, Tai, Shiao, Stephen L, Lorber, Marc I, Sessa, William C, Tellides, George, Pober, Jordan S

    Published in The Journal of clinical investigation (01-09-2004)
    “…Allograft vascular dysfunction predisposes to arteriosclerosis and graft loss. We examined how dysfunction develops in transplanted human arteries in response…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Interferon-γ elicits arteriosclerosis in the absence of leukocytes by Tellides, George, Tereb, Denis A, Kirkiles-Smith, Nancy C, Kim, Richard W, Wilson, Jean H, Schechner, Jeffrey S, Lorber, Marc I, Pober, Jordan S

    Published in Nature (London) (13-01-2000)
    “…Atherosclerosis and post-transplant graft arteriosclerosis are both characterized by expansion of the arterial intima as a result of the infiltration of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Renal Allograft Failure Predictors After PAK Transplantation: Results From the New England Collaborative Association of Pancreas Programs by PAVLAKIS, Martha, KHWAJA, Khalid, MANDELBROT, Didier, HONGYING TANG, WHITING, James W, LORBER, Marc I, GAUTAM, Amitabh, JOHNSON, Scott R, UKNIS, Marc E

    Published in Transplantation (15-06-2010)
    “…The reasons for kidney allograft failure subsequent to pancreas after kidney (PAK) are multifactorial; therefore, we examined these factors to identify a…”
    Get full text
    Journal Article
  13. 13

    A Multicenter Pilot Study of Early (4‐Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and Sirolimus by Woodle, E. Steve, Vincenti, Flavio, Lorber, Marc I., Gritsch, H. Albin, Hricik, Donald, Washburn, Kenneth, Matas, Arthur J., Gallichio, Michael, Neylan, John

    Published in American journal of transplantation (01-01-2005)
    “…This study presents the first prospective multicenter study assessing sirolimus‐based immunosuppression with early (4‐day) corticosteroid withdrawal (CSWD) in…”
    Get full text
    Journal Article
  14. 14

    Pig but not Human Interferon-γ Initiates Human Cell-Mediated Rejection of Pig Tissue in vivo by Sultan, Parvez, Murray, Allan G., McNiff, Jennifer M., Lorber, Marc I., Askenase, Philip W., Alfred L. M. Bothwell, Pober, Jordan S.

    “…Split-thickness pig skin was transplanted on severe combined immunodeficient mice so that pig dermal microvessels spontaneously inosculated with mouse…”
    Get full text
    Journal Article
  15. 15

    Development of a Humanized Mouse Model to Study the Role of Macrophages in Allograft Injury by KIRKILES-SMITH, Nancy C, HARDING, Martha J, POBER, Jordan S, SHEPHERD, Benjamin R, FADER, Stacey A, TAI YI, YINONG WANG, MCNIFF, Jennifer M, SNYDER, Edward L, LO RBER, Marc I, TEIIIDES, George

    Published in Transplantation (27-01-2009)
    “…Nearly half of all infiltrating leukocytes in rejecting human allografts are macrophages, yet, in comparison with T cells, much less is known about the…”
    Get full text
    Journal Article
  16. 16

    A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period by Formica, Richard N., Friedman, Amy L., Lorber, Marc I., Smith, J. Douglas, Eisen, Tom, Bia, Margaret J.

    Published in Nephrology, dialysis, transplantation (01-05-2006)
    “…Background. Blockade of the renin–angiotensin–aldosterone system in the early post-transplant period remains controversial. Angiotensin II-receptor blockers…”
    Get full text
    Journal Article
  17. 17

    Amelioration of Human Allograft Arterial Injury by Atorvastatin or Simvastatin Correlates With Reduction of Interferon-γ Production by Infiltrating T Cells by TAI YI, RAO, Deepak A, TANG, Paul C. Y, YINONG WANG, CUCHARA, Lisa A, BOTHWELL, Alfred L. M, COLANGELO, Christopher M, TELLIDES, George, POBER, Jordan S, LORBER, Marc I

    Published in Transplantation (15-09-2008)
    “…Graft arteriosclerosis (GA) is an important factor limiting long-term outcomes after organ transplantation. We have used a chimeric humanized mouse system to…”
    Get full text
    Journal Article
  18. 18

    Interferon‐γ plays a nonredundant role in mediating T‐cell‐ dependent outward vascular remodeling of allogeneic human coronary arteries by Wang, Yinong, Burns, William R., Tang, Paul C. Y., Yi, Tai, Schechner, Jeffrey S., Zerwes, Hans‐Guenter, Sessa, William C., Lorber, Marc I., Pober, Jordan S., Tellides, George

    Published in The FASEB journal (01-03-2004)
    “…Vascular remodeling (change in vessel diameter) rather than intimal hyperplasia is the most important predictor of luminal loss in immune‐mediated arterial…”
    Get full text
    Journal Article
  19. 19

    Prospective Observational Study of Sirolimus as Primary Immunosuppression After Renal Transplantation by PESCOVITZ, Mark D, NEZAKATGOO, Nosratollah, LORBER, Marc I, NASHAN, Bjorn, TEDESCO-SILVA, Helio, KASISKE, Bertram L, JUAREZ DE LA CRUZ, Federico J, RUSS, Graeme, CAMPISTOL, Joseph, KEOWN, Paul A

    Published in Transplantation (27-10-2009)
    “…BACKGROUND.: Sirolimus (SRL) is an important component of clinical immunosuppression in renal transplantation, but few international studies have examined how…”
    Get full text
    Journal Article
  20. 20